S2E5: Practical Approaches to Cardiovascular Risk Reduction in the Era of PCSK9 Inhibitors

Dr. Alan Brown sits down with Kim Birtcher, PharmD, Adjunct Clinical Professor at the University of Houston College of Pharmacy to discuss approaches to cardiovascular risk reduction in the age of modern therapies such as PCSK9 inhibitors.